Intensity Therapeutics Appoints New Chief Medical Officer
Ticker: INTS · Form: 8-K · Filed: Oct 23, 2024 · CIK: 1567264
| Field | Detail |
|---|---|
| Company | Intensity Therapeutics, Inc. (INTS) |
| Form Type | 8-K |
| Filed Date | Oct 23, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $3.44 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, biotech, personnel
TL;DR
Intensity Therapeutics just hired a new CMO, Dr. Robert Ferris, to push their cancer drugs forward.
AI Summary
Intensity Therapeutics, Inc. announced on October 21, 2024, the appointment of Dr. Robert L. Ferris as Chief Medical Officer and a member of the Board of Directors. Dr. Ferris brings extensive experience in oncology drug development and clinical trials. This appointment is expected to bolster the company's efforts in advancing its novel cancer therapies.
Why It Matters
The appointment of a seasoned Chief Medical Officer like Dr. Ferris is crucial for advancing Intensity Therapeutics' drug pipeline, potentially leading to new treatments for cancer patients.
Risk Assessment
Risk Level: medium — The company is in the biotechnology sector, which is inherently risky due to the long and uncertain drug development process.
Key Players & Entities
- Intensity Therapeutics, Inc. (company) — Registrant
- Dr. Robert L. Ferris (person) — Appointed Chief Medical Officer and Board Member
- October 21, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Shelton, CT (location) — Principal Executive Offices
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Robert L. Ferris has been appointed as the new Chief Medical Officer.
When was the earliest event reported in this filing?
The earliest event reported was on October 21, 2024.
What is the principal executive office address of Intensity Therapeutics, Inc.?
The principal executive office address is 1 Enterprise Drive, Suite 430, Shelton, CT 06484-4779.
What is the Commission File Number for Intensity Therapeutics, Inc.?
The Commission File Number is 001-41109.
In which state is Intensity Therapeutics, Inc. incorporated?
Intensity Therapeutics, Inc. is incorporated in Delaware.
Filing Stats: 527 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2024-10-23 16:20:10
Key Financial Figures
- $0.0001 — nge on Which Registered: Common Stock, $0.0001 par value per share INTS The Nasdaq Sto
- $3.44 — e Plan. The Options are exercisable for $3.44 per share, the fair market value of the
Filing Documents
- intensity-20241021.htm (8-K) — 24KB
- 0001567264-24-000045.txt ( ) — 151KB
- intensity-20241021.xsd (EX-101.SCH) — 2KB
- intensity-20241021_lab.xml (EX-101.LAB) — 23KB
- intensity-20241021_pre.xml (EX-101.PRE) — 13KB
- intensity-20241021_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 23, 2024 Intensity Therapeutics, Inc. By: /s/ Lewis H. Bender Name: Lewis H. Bender Title: Chief Executive Officer 2